Central Data Catalog

Citation Information

Type Journal Article - Archives of Iranian medicine
Title The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran: a population-based study
Author(s)
Volume 12
Issue 3
Publication (Day/Month/Year) 2009
Page numbers 225-231
URL http://eprints.goums.ac.ir/2590/1/The_Prevalence_of_Hepatitis_B_Surface_Antigen_and_Anti-Hepatitis_B​_Core_Antibody_in_Iran.pdf
Abstract
Background: Hepatitis B virus infection is a very common cause of chronic liver disease
worldwide. It is estimated that 3% of Iranians are chronically infected with hepatitis B virus. Current
population-based studies on both rural and urban prevalence of hepatitis B virus infection in Iran
are sparse with results that do not always agree. We performed this study to find the prevalence of
hepatitis B surface antigen, anti-hepatitis B core antibody, and associated factors in the general
population of three provinces of Iran.
Methods: We randomly selected 6,583 subjects from three provinces in Iran, namely Tehran,
Golestan, and Hormozgan. The subjects were aged between 18 and 65 years. Serum samples were
tested for hepatitis B surface antigen and anti-hepatitis B core antibody. Various risk factors were
recorded and multivariate analysis was performed.
Results: The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in
Iran was 2.6% and 16.4%, respectively. Predictors of hepatitis B surface antigen or anti-hepatitis B
core antibody in multivariate analysis included older age, not having high-school diploma, living in
a rural area, and liver disease in a family member. We did not find any significant differences
between males and females.
Conclusion: In spite of nationwide vaccination of newborns against hepatitis B virus since
1992, hepatitis B virus infection remains a very common cause of chronic liver disease in Iran
which should be dealt with for at least the next 30 – 50 years.

Related studies

»